Overview
Michelle Lynn Hall is Co-Founder and General Partner of Entrée Bio at Entrée Capital, an early-stage biotech fund focused on translating biological insight into scalable therapeutic impact [1][2]. Hall brings operational experience from roles across the pharmaceutical and biotechnology sectors, having led computational and experimental teams in genetic medicines and drug discovery at Schrödinger, Moderna, and Eli Lilly [2]. At Eli Lilly, Hall held positions including Director of RNA Innovation, Senior Director of New Therapeutic Modalities, Senior Director of Genetic Medicine, and Associate Vice President between 2020 and 2025 [4][5][6][7]. Hall earned a Ph.D. in Chemistry from Columbia University in 2011, along with an M.Phil. and M.A. in Chemistry from the same institution [11][12][13]. Hall served as Chair Elect, Chair, and Past Chair of the American Chemical Society in 2018, 2019, and 2020 respectively [8][9][10].
Profile introduction
I'm a Co-founder and General Partner of Entrée Bio, an early-stage biotech fund spinout of Entrée Capital, where I invest in companies that translate deep biological insight into scalable therapeutic impact. I come to venture from the operator side. I’ve led computational and experimental teams in genetic medicines and drug discovery, working across modalities including small molecules, biologics, oligonucleotides, mRNA, gene editing, and non-viral delivery at Schrödinger, Moderna, and Eli Lilly. That experience shapes how I invest. I’m drawn to platforms and programs that are grounded in…
Career history
- Co-Founder & General Partner, Entrée BioOct 2025 to presentEntrée Capital
- Associate Vice PresidentMar 2022 to Sep 2025Eli Lilly and Company
- Senior Director, Genetic MedicineDec 2021 to Mar 2022Eli Lilly and Company
- Senior Director, New Therapeutic ModalitiesSep 2020 to Dec 2021Eli Lilly and Company
- Director of RNA InnovationApr 2020 to Sep 2020Eli Lilly and Company
- Past ChairJan 2020 to Dec 2020American Chemical Society
- ChairJan 2019 to Dec 2019American Chemical Society
- Chair ElectJan 2018 to Dec 2018American Chemical Society
Education
Ph.D, Chemistry2010 - 2011Columbia University
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.